Alnylam Pharma (ALNY) to Offer $675M in Common Stock
November 13, 2017 7:02 AM
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the commencement of an underwritten public offering of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
